DataMeds AI, Inc. (MEDS) Form 10-K Annual Reports
DataMeds AI, Inc. (MEDS) is a publicly traded company on the Nasdaq, categorized under SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MEDS
CIK: 2030763
Exchange: Nasdaq
SIC 5122: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
SURI AND CO
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerHarieharan M
Audit LocationBengaluru, India
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-13 | 8-K | 0001493152-26-047451 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001493152-26-046887 | View SEC Doc Filr Page |
| PRE 14C | 2026-10-09 | 2026-10-09 | PRE 14C | 0001493152-26-046610 | View SEC Doc Filr Page |
| S-1/A | 2026-10-09 | — | S-1/A | 0001493152-26-046608 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-11 | 8-K | 0001493152-26-043169 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-11 | 8-K | 0001493152-26-042951 | View SEC Doc Filr Page |
| PRE 14C | 2026-08-31 | 2026-08-31 | PRE 14C | 0001493152-26-040878 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-17 | 8-K | 0001493152-26-038891 | View SEC Doc Filr Page |
| 10-Q | 2026-08-17 | 2026-06-30 | 10-Q | 0001493152-26-038581 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001493152-26-038475 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038378 | View SEC Doc Filr Page |
| S-1 | 2026-08-07 | — | S-1 | 0001493152-26-036665 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-29 | 8-K | 0001493152-26-036005 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-27 | 8-K | 0001493152-26-035058 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-20 | 8-K | 0001493152-26-034086 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-22 | 4 | 0001493152-26-030154 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-22 | 4 | 0001493152-26-030151 | View SEC Doc Filr Page |
| 4/A | 2026-06-25 | 2026-03-31 | 4/A | 0001493152-26-030122 | View SEC Doc Filr Page |
| 4/A | 2026-06-25 | 2026-03-31 | 4/A Filing | 0001493152-26-030123 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-18 | 2026-06-18 | PRE 14A | 0001493152-26-029351 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-09 | 8-K | 0001493152-26-028464 | View SEC Doc Filr Page |
| DRS/A | 2026-06-11 | — | DRS/A Filing | 0001493152-26-028189 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-03 | 2026-05-27 | 8-K/A | 0001493152-26-027063 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-02 | 2026-05-27 | 8-K/A | 0001493152-26-026879 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-27 | 8-K | 0001493152-26-026452 | View SEC Doc Filr Page |